文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

一种用于预测川崎病患者复发性冠状动脉血栓形成的列线图模型。

A Nomogram Model for Predicting Recurrent Coronary Thrombosis in Kawasaki Disease Patients.

作者信息

Zhou Xue, Peng Yue, Yi Qijian

机构信息

Department of Cardiovascular Medicine, Children's Hospital of Chongqing Medical University, Chongqing, People's Republic of China.

National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, People's Republic of China.

出版信息

J Inflamm Res. 2025 Jan 3;18:105-114. doi: 10.2147/JIR.S473511. eCollection 2025.


DOI:10.2147/JIR.S473511
PMID:39780986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11705992/
Abstract

BACKGROUND: Coronary thrombosis is a serious cardiovascular complication of Kawasaki disease (KD), and recurrence of coronary thrombosis increases the short-term risk of myocardial infarction and the long-term risk of coronary artery disease. However, there are currently no studies predicting the recurrence of coronary thrombosis, so the aim of this study was to develop and validate a nomogram to predict recurrent coronary thrombosis in KD patients. METHODS: This was a retrospective study of data from 149 KD patients who had a history of previous coronary disease at the Children's Hospital of Chongqing Medical University from 2013 to 2020. Independent risk factors were identified using univariate and multivariate logistic regression analyses, and a nomogram was constructed to predict recurrent coronary thrombosis. RESULTS: Multivariate analysis showed that large coronary artery aneurysm(CAA) (Odds Ratio [OR] 4.28; 95% Confidence Interval [CI] 1.39-13.12), saccular CAA (OR 5.03; 95% CI 1.55-16.29), first left anterior descending (LAD) thrombosis (OR 3.90; 95% CI 1.20-12.63), and persistent CAA (OR 43.27; 95% CI 12.23-153.12) were independent risk factors for recurrent coronary thrombosis. Based on these variables, a nomogram was constructed. The Area Under the Curve (AUC) of the nomogram was 0.943, and tenfold cross-validation (200 replicates) showed an average AUC of 0.929. Furthermore, the nomogram not only presented a favorable calibration curve but also demonstrated practical clinical utility. CONCLUSION: Large CAA, saccular CAA, first LAD thrombosis and persistent CAA were independent risk factors for recurrent coronary thrombosis. The nomogram can visually show these independent risk factors and predict probabilities.

摘要

背景:冠状动脉血栓形成是川崎病(KD)严重的心血管并发症,冠状动脉血栓复发会增加心肌梗死的短期风险和冠状动脉疾病的长期风险。然而,目前尚无预测冠状动脉血栓复发的研究,因此本研究旨在建立并验证一种列线图,以预测KD患者冠状动脉血栓的复发。 方法:这是一项对2013年至2020年重庆医科大学附属儿童医院149例既往有冠状动脉疾病史的KD患者的数据进行的回顾性研究。采用单因素和多因素逻辑回归分析确定独立危险因素,并构建列线图以预测冠状动脉血栓复发。 结果:多因素分析显示,大型冠状动脉瘤(CAA)(比值比[OR]4.28;95%置信区间[CI]1.39 - 13.12)、囊状CAA(OR 5.03;95% CI 1.55 - 16.29)、首次左前降支(LAD)血栓形成(OR 3.90;95% CI 1.20 - 12.63)和持续性CAA(OR 43.27;95% CI 12.23 - 153.12)是冠状动脉血栓复发的独立危险因素。基于这些变量,构建了列线图。列线图的曲线下面积(AUC)为0.943,十折交叉验证(200次重复)显示平均AUC为0.929。此外,列线图不仅呈现出良好的校准曲线,还具有实际临床应用价值。 结论:大型CAA、囊状CAA、首次LAD血栓形成和持续性CAA是冠状动脉血栓复发的独立危险因素。列线图可以直观地显示这些独立危险因素并预测概率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11705992/ad1da500cde1/JIR-18-105-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11705992/51432c05d8a0/JIR-18-105-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11705992/5659d34688dd/JIR-18-105-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11705992/823fa256c70e/JIR-18-105-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11705992/74f3bb1d7f5e/JIR-18-105-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11705992/ad1da500cde1/JIR-18-105-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11705992/51432c05d8a0/JIR-18-105-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11705992/5659d34688dd/JIR-18-105-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11705992/823fa256c70e/JIR-18-105-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11705992/74f3bb1d7f5e/JIR-18-105-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11705992/ad1da500cde1/JIR-18-105-g0005.jpg

相似文献

[1]
A Nomogram Model for Predicting Recurrent Coronary Thrombosis in Kawasaki Disease Patients.

J Inflamm Res. 2025-1-3

[2]
A practical nomogram for predicting coronary thrombosis for Kawasaki disease patients with medium or large coronary artery aneurysm.

Clin Exp Med. 2023-8

[3]
Nomogram model based on serum chitotriosidase activity to predict coronary artery aneurysm in Kawasaki disease.

Coron Artery Dis. 2025-9-1

[4]
Development of a nomogram prediction model for early identification of persistent coronary artery aneurysms in kawasaki disease.

BMC Pediatr. 2023-2-16

[5]
Prognostic nutritional index value in the prognosis of Kawasaki disease with coronary artery lesions.

Front Nutr. 2023-2-1

[6]
Nomogram for predicting coronary artery lesions in patients with Kawasaki disease.

Clin Cardiol. 2023-11

[7]
A visualized nomogram to predict intravenous immunoglobulin resistance in Kawasaki disease: a study based on the population in Southern China.

Ital J Pediatr. 2025-4-12

[8]
Kawasaki disease coronary artery lesions prediction with monocyte-to-high-density lipoprotein ratio.

Pediatr Res. 2023-7

[9]
Incidence and timing of coronary thrombosis in Kawasaki disease patients with giant coronary artery aneurysm.

Thromb Res. 2023-1

[10]
Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China.

Ann Med. 2022-12

本文引用的文献

[1]
Intravenous immunoglobulin for the treatment of Kawasaki disease.

Cochrane Database Syst Rev. 2023-1-25

[2]
Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study.

Pediatr Rheumatol Online J. 2022-12-5

[3]
A practical nomogram for predicting coronary thrombosis for Kawasaki disease patients with medium or large coronary artery aneurysm.

Clin Exp Med. 2023-8

[4]
Kawasaki Disease: Pathology, Risks, and Management.

Vasc Health Risk Manag. 2022

[5]
Incidence of Restenosis Following Rapamycin or Paclitaxeleluting Stent in Coronary Stent Implantation.

Cardiovasc Hematol Disord Drug Targets. 2021

[6]
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.

Lancet Child Adolesc Health. 2021-12

[7]
Anatomic and Flow Characteristics of Left Anterior Descending Coronary Artery Angiographic Stenoses Predisposing to Myocardial Infarction.

Am J Cardiol. 2021-2-15

[8]
Persistence of Intraluminal Thrombus Makes Saccular Aneurysm More Biologically Active than Fusiform in an Experimental Rat Model.

J Vasc Res. 2020

[9]
Lifetime cardiovascular management of patients with previous Kawasaki disease.

Heart. 2019-12-16

[10]
Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease.

JAMA Pediatr. 2018-12-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索